TALVEY® (talquetamab-tgvs) resources for care partners
As a care partner, you play an important role in supporting your loved one throughout their multiple myeloma journey. Beginning a new treatment can be daunting, and it’s normal to wonder what to expect. Below, you’ll find information on what’s to come and how you can provide meaningful support.
You can help the person in your care prepare to receive treatment with TALVEY® (talquetamab-tgvs)Before the person in your care starts TALVEY®, ensure they inform their healthcare provider if they:
Have an infection
Are pregnant or plan to become pregnant. TALVEY® may harm the unborn baby. Tell the healthcare provider if the person in your care becomes pregnant or thinks that they may be pregnant during treatment with TALVEY®
For females who are able to become pregnant:
- The healthcare provider should do a pregnancy test before the person in your care starts treatment with TALVEY®
- Women should use effective birth control (contraception) during treatment and for 3 months after the last dose of TALVEY®
For women who are breastfeeding or plan to breastfeed: It is not known if TALVEY® passes into the breast milk. Do not breastfeed during treatment and for 3 months after the last dose of TALVEY®
Tell the healthcare provider about all the medicines the person in your care takes, including prescription and over-the-counter medicines, vitamins, and herbal supplements
You can help the person in your care plan for the 48-hour hospitalization during the step-up dosing schedule by:
Reviewing hospital policies around visiting them while they are hospitalized
Helping them pack a bag for their hospitalization that includes things like a blanket, headphones, a phone charger, a book or magazine to read, any forms needed, or any picture frames to keep bedside
Arranging for someone to care for any of their children, pets, or plants for the length of their hospitalization; resources like a local chapter of a group like the American Cancer Society can help with this
It might be helpful for the person in your care to wear comfortable clothing because the injection site can be located on the stomach area (abdomen) or thigh
Because the person in your care cannot drive after treatment, you can help by arranging transportation to and from their appointment
You can help ensure the person in your care does not drive, operate heavy machinery, or do other dangerous activities during and for 48 hours after their TALVEY® step-up dose is completed or at any time during treatment with TALVEY®. If the person in your care develops dizziness, confusion, tremors, sleepiness, or any other symptoms of neurologic problems after any TALVEY® doses, do not let them drive, operate heavy machinery, or do other dangerous activities until their symptoms go away. These may be signs and symptoms of cytokine release syndrome and neurologic problems and require immediate medical attention
You can help the person in your care with their side effects by:
- Encouraging them to use the symptom tracker in the My Journey With TALVEY® Guide
- Informing their healthcare provider of any side effects they may be experiencing
- Asking the healthcare provider what can be done about any side effects
Write down any additional questions you or the person in your care have so you can remember to ask them at the next appointment.
The facility where the person in your care receives their step-up dosing may be different from where they receive their treatment doses. Make sure to double-check where TALVEY® will be given during the step-up dosing schedule and treatment dosing schedule.
Resources for care partners
Get more tips and information about taking care of yourself and the person in your care.
Inspire others
If TALVEY® has helped you or a loved one manage multiple myeloma, we want to hear from you. Share your story so that you can help inspire others like you.
Share your storyHCP, healthcare provider; REMS, Risk Evaluation and Mitigation Strategy.